Owner Teijin Pharma Limited

Inventors Hisamatsu, Seiichi; Kanou, Masanobu; Nakajima, Ryota; Nishiwaki, Yasumi; Nakano, Akira; Kurokawa, Masayuki

Agent Davies Collison Cave

Pub. Number AU-A-2008221833

PCT Pub. Number WO2008/108486

Priority 2007-055923 06.03.07 JP; 2007-202109 02.08.07 JP

Filing date 4 March 2008

Wipo publication date 12 September 2008

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61K 31/404 (2006.01)

A61K 31/4427 (2006.01) - containing further heterocyclic ring systems

A61K 31/497 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/706 (2006.01)

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07H 15/26 (2006.01) Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals